Key statistics
On Tuesday, Akari Therapeutics PLC (CLA:DUS) closed at 2.54, 24.51% above the 52 week low of 2.04 set on Oct 07, 2024.
52-week range
Open | 2.48 |
---|---|
High | 2.54 |
Low | 2.48 |
Bid | -- |
Offer | -- |
Previous close | 2.54 |
Average volume | 1.00 |
---|---|
Shares outstanding | 607.23k |
Free float | 485.78k |
P/E (TTM) | -- |
Market cap | 36.86m USD |
EPS (TTM) | -2.98 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 18:32 BST.
More ▼
Announcements
- Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics
- Akari Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights
- Akari Therapeutics Receives Positive and Constructive Pre-IND Feedback from US FDA for PAS-nomacopan in Treatment of Geographic Atrophy
- Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders
- Akari Therapeutics Secures $7.6 Million in Upsized Financing Round
- Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
- Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
- Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
- Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024
- Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
More ▼